Immunology and New Concepts in Immunotherapy
About us
Created in 2022, the INCIT(Immunology and New Concepts in Immunotherapy) research unit, directed by Frédéric Altare, is based on the desire to focus thescientific expertise of the immunology and immunotherapy teams on different pathological contexts: inflammation, cancer and infectious diseases.
Workforce
Publications since 2016
Doctoral students and post-docs
Locations - Nantes and Angers
Teams of specialists
INCIT brings together a wide range of immunology skills among its 4 teams, with a common objective:
To decipher the cellular and molecular mechanisms associated with immune responses to develop immunotherapeutic strategies.
Our news
"2 prizes for Incit at the Go Immuno congress - December 11 & 12, 2023".
INCIT was honored at the "Go Immuno" conference organized by Labex IGO in December. Margaux Verdon (team 1) was awarded the prize for best poster, while Gwenann Cadiou (team 3) won the prize for best oral communication!
"2 prizes for Incit at the Go Immuno congress - December 11 & 12, 2023".
INCIT was honored at the "Go Immuno" conference organized by Labex IGO in December. Margaux Verdon (team 1) was awarded the prize for best poster, while Gwenann Cadiou (team 3) won the prize for best oral communication!
"Cross-talks between Death Receptor signalling and ER stress response in cancer".
Dr Elodie Lafont (U1242 Inserm, Centre Eugène Marquis, Rennes), guest of Team 2, will give a seminar entitled: Cross-talks between Death Receptor signalling and ER stress response in cancer , on November 27 at 14.00 - Rooms 1, 2, 3 - IRS2, Nantes
"Reactivation of the STING pathway to improve the efficacy of immunotherapies (anti-PD(L)1) in heterotypic spheroid models of urothelial carcinoma."
Dr Céline Gongora (Institut de cancérologie de Montpellier (IRCM), guest of Team 3, will give a seminar entitled: Reactivation of the STING pathway to improve the efficacy of immunotherapies (anti-PD-(L)1) in urothelial carcinoma models , June 21 at 11.00 - Rooms 1, 2, 3 - IRS2, Nantes